The Consequences of Prenatal Tobacco Exposure: A Systematic Review of Birth Outcomes and Developmental Trajectories

Kadambari Ambildhok1, Kailash Asawa1

  • 1Department of Dentistry, Pacific Academy of Higher Education and Research, Udaipur, IND.

Cureus
|April 27, 2026
PubMed

Insights

Prenatal tobacco exposure significantly increases risks for low birth weight and adverse neurodevelopmental outcomes in children. Smoking cessation interventions during pregnancy are crucial for preventing these negative health consequences.

Area of Science:

  • Public Health
  • Perinatal Medicine
  • Developmental Psychology

Background:

  • Prenatal tobacco exposure is a major preventable public health issue.
  • Maternal smoking during pregnancy is linked to adverse perinatal and long-term developmental effects.
  • Understanding these associations is critical for intervention strategies.

Purpose of the Study:

  • To systematically review the association between prenatal tobacco exposure and offspring birth and developmental outcomes.
  • To synthesize evidence on the impact of maternal smoking on fetal growth and child development.
  • To evaluate the certainty of evidence for these associations.

Main Methods:

  • Systematic review adhering to PRISMA 2020 guidelines.
  • Searched six databases for observational studies (June 2014-June 2025).
  • Assessed risk of bias (ROBINS-I) and certainty of evidence (GRADE).

Main Results:

  • Prenatal tobacco exposure consistently linked to increased low birth weight (OR 2.24-2.91) and reduced birth weight (230-300g).
  • Confirmed reductions in birth weight and head circumference via biomarker studies.
  • Associated with impaired attention, executive function, fine motor skills, academic performance, and increased psychiatric disorders (ADHD, disruptive behavior disorder).

Conclusions:

  • Prenatal tobacco exposure is strongly associated with reduced fetal growth and adverse neurodevelopmental and psychiatric outcomes.
  • Evidence for smokeless tobacco exposure is limited.
  • Prioritizing smoking cessation interventions during pregnancy is essential to mitigate adverse child health outcomes.

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.2K
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
62
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by...
1.7K
Stress Prevention and Stress Management Techniques IV01:26

Stress Prevention and Stress Management Techniques IV

Stress often leads to unhealthy habits like smoking, excessive drinking, and overeating, which offer short-term relief but ultimately increase long-term health risks. These behaviors create a cycle that temporarily lowers stress levels but can result in severe long-term health consequences. Breaking these habits is essential to reduce the risk of chronic diseases and improve overall well-being. Three primary changes that support better health include quitting smoking, reducing alcohol intake,...
365
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
29
Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
1.4K